The Hidden Passenger: New Findings on Mesenchymal Stem Cell Viral Safety

Imagine a patient with a failing immune system receiving a dose of healing cells, unaware that a dormant virus is hitched to the genetic code of every single one. This silent stowaway represents a hidden risk in the most sophisticated medicines available today.

Mesenchymal stem cells (MSCs) are currently used to treat autoimmune disorders and organ rejection. Because these patients often have suppressed immune systems, the purity of the cell product is a matter of survival. However, standard screening protocols may have a blind spot regarding viruses that hide inside the donor's own DNA.

In an early-stage preprint awaiting peer review, researchers analysed clinical-grade MSCs derived from umbilical cord tissue. They identified Human herpesvirus 6 (HHV-6B) DNA within the cells. Using advanced sequencing, they found the virus had integrated into the telomeric region of chromosome 19. This means the viral code persists through every cell division, effectively becoming a permanent part of the cell's architecture.

Strengthening Mesenchymal Stem Cell Viral Safety Standards

While the study found no active viral replication, the presence of a full viral genome raises questions about potential reactivation once the cells are inside a patient. These preliminary findings suggest that current quality control strategies may need to be expanded to include more sensitive genomic testing.

• Integrated viruses can bypass traditional liquid-based contamination tests.
• HHV-6B is widespread but can cause severe complications in immunocompromised recipients.
• Long-read sequencing may be required to ensure the genetic integrity of donor cells.

The research suggests that ensuring the safety of these living medicines requires a deeper look into the chromosomal makeup of donor tissue than previously recognised.